A multicenter phase IV study to investigate the immunogenicity of recombinant human follicle-stimulating hormone and its impact on clinical outcomes in females undergoing controlled ovarian stimulation

• Hoofdauteurs: Abha Majumdar (Auteur), Le Hoang (Auteur), Ly T Loc (Auteur), Padma Srivastava (Auteur), Chitra Ramamurthy (Auteur), Ratnabali Chakravorty (Auteur), Yogeshwar S Nandanwar (Auteur), M D Rashmi (Auteur), Rahul V Mayekar (Auteur), Jayashree Sridhar (Auteur), Ganesh H Divekar (Auteur), James John (Auteur)
• Formaat: Boek
• Gepubliceerd in: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Context: Therapeutic proteins can cause immune responses, which may have clinical implications. Aims: The aim of the study was to assess the immunogenicity of recombinant human follicle-stimulating hormone (r-hFSH), when used for controlled ovarian stimulation (COS). Settings and Design: Prospective...